Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Indian Immunologicals Limited Snapshot 5 Indian Immunologicals Limited Overview 5 Key Information 5 Key Facts 5 Indian Immunologicals Limited - Research and Development Overview 6 Key Therapeutic Areas 6 Indian Immunologicals Limited - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Indian Immunologicals Limited - Pipeline Products Glance 11 Indian Immunologicals Limited - Clinical Stage Pipeline Products 11 Phase I Products/Combination Treatment Modalities 11 Indian Immunologicals Limited - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Indian Immunologicals Limited - Unknown Stage Pipeline Products 13 Unknown Products/Combination Treatment Modalities 13 Indian Immunologicals Limited - Drug Profiles 14 (diphtheria + Haemophilus influenza [serotype B] + hepatitis B + pertussis (wholl cell) + tetanus) (pentavalent) vaccine 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 chikungunya vaccine 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 human papillomavirus [serotypes 16, 18] vaccine 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Japanese encephalitis vaccine 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Alphavirus vaccine 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 flavivirus vaccine 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 picornavirus vaccine 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Vaccine for Undisclosed Indication 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Indian Immunologicals Limited - Pipeline Analysis 22 Indian Immunologicals Limited - Pipeline Products by Target 22 Indian Immunologicals Limited - Pipeline Products by Route of Administration 23 Indian Immunologicals Limited - Pipeline Products by Molecule Type 24 Indian Immunologicals Limited - Recent Pipeline Updates 25 Indian Immunologicals Limited - Dormant Projects 26 Indian Immunologicals Limited - Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29

List of Tables Indian Immunologicals Limited, Key Information 5 Indian Immunologicals Limited, Key Facts 5 Indian Immunologicals Limited - Pipeline by Indication, 2016 7 Indian Immunologicals Limited - Pipeline by Stage of Development, 2016 8 Indian Immunologicals Limited - Monotherapy Products in Pipeline, 2016 9 Indian Immunologicals Limited - Combination Treatment Modalities in Pipeline, 2016 10 Indian Immunologicals Limited - Phase I, 2016 11 Indian Immunologicals Limited - Preclinical, 2016 12 Indian Immunologicals Limited - Unknown, 2016 13 Indian Immunologicals Limited - Pipeline by Target, 2016 22 Indian Immunologicals Limited - Pipeline by Route of Administration, 2016 23 Indian Immunologicals Limited - Pipeline by Molecule Type, 2016 24 Indian Immunologicals Limited - Recent Pipeline Updates, 2016 25 Indian Immunologicals Limited - Dormant Developmental Projects,2016 26 Indian Immunologicals Limited, Other Locations 27 List of Figures Indian Immunologicals Limited - Pipeline by Top 10 Indication, 2016 7 Indian Immunologicals Limited - Pipeline by Stage of Development, 2016 8 Indian Immunologicals Limited - Monotherapy Products in Pipeline, 2016 9 Indian Immunologicals Limited - Pipeline by Route of Administration, 2016 23 Indian Immunologicals Limited - Pipeline by Molecule Type, 2016 24